Related Experiment Video
Updated: Aug 16, 2026

Tools to Study the Role of Architectural Protein HMGB1 in the Processing of Helix Distorting, Site-specific DNA Interstrand Crosslinks
Published on: November 10, 2016
Topoisomerase II-DNA complexes trapped by ICRF-193 perturb chromatin structure
1Laboratoire de Génétique Moléculaire, Ecole Normale Supérieure, Paris, France.
Abstract:
DNA topoisomerase II (topo II) is involved in unlinking replicating DNA and organizing mitotic chromosomes. Topo II is the target of many antitumour drugs. Topo II inhibition results in extensive catenation of newly replicated DNA and may potentially perturb chromatin assembly. Here, we show that the topo II inhibitor ICRF-193 does not prevent the bulk of nucleosome deposition, but perturbs nucleosome spacing in Xenopus egg extracts. This is due to the trapping of topo II-closed clamps on the DNA rather than increased DNA catenation. Inhibition of replicative DNA decatenation has in itself little or no effect on nucleosome deposition and spacing, suggesting that DNA can easily accommodate the sharp bending constraints imposed by the co-habitation of nucleosomes and catenane nodes. Chromatin perturbation by topo II clamps may explain some dominant cellular effects of ICRF-193. Nucleosome-driven bending of precatenane nodes may facilitate their unlinking by topo II during unperturbed replication.
Insights
DNA topoisomerase II (topo II) inhibitors like ICRF-193 disrupt nucleosome spacing by trapping DNA-bound clamps, not by increasing DNA catenation. This chromatin perturbation impacts cellular effects.
Area of Science:
- Molecular Biology
- Cell Biology
- Biochemistry
Background:
- DNA topoisomerase II (topo II) is crucial for DNA replication and chromosome organization.
- Topo II is a validated target for anticancer therapies.
- Inhibiting topo II can lead to DNA catenation and potentially disrupt chromatin assembly.
Purpose of the Study:
- To investigate the effects of the topo II inhibitor ICRF-193 on nucleosome deposition and spacing.
- To determine whether DNA catenation or trapped topo II clamps are responsible for chromatin perturbation.
Main Methods:
- Experiments were conducted using Xenopus egg extracts.
- Nucleosome deposition and spacing were analyzed following treatment with the topo II inhibitor ICRF-193.
- The roles of DNA decatenation and trapped topo II clamps were assessed.
Main Results:
- ICRF-193 treatment did not inhibit bulk nucleosome deposition.
- Nucleosome spacing was perturbed by ICRF-193, attributed to trapped topo II-closed clamps.
- Inhibition of DNA decatenation alone had minimal impact on nucleosome deposition and spacing.
Conclusions:
- Topo II clamps, rather than DNA catenation, are the primary cause of chromatin perturbation by ICRF-193.
- DNA can accommodate nucleosomes and catenane nodes simultaneously.
- Chromatin perturbation by topo II clamps may underlie the cellular effects of ICRF-193.
Related Concept Videos
DNA Topoisomerases
Types and Mechanism of action
Topoisomerases are divided into two main types. Type I...
Condensins
The plant and animal cells contain two types of condensin complexes—condensin I and condensin II. Both complexes have five subunits: two SMC (Structural Maintenance of Chromosomes) subunits, a kleisin subunit, and two HEAT-repeat...
Nucleosome Remodeling
Nucleosome remodeling complex
Eukaryotic cells have specialized enzymes called ATP-dependent nucleosome remodeling enzymes. These enzymes...
Restarting Stalled Replication Forks
Conservative Site-specific Recombination and Phase Variation
The recognition sites for Cre recombinase called LoxP...
Inhibitors of Bacterial DNA Synthesis

